Feed Preview

Angiogenesis Inhibitors to Treat Cancer

Angiogenesis Inhibitors to Treat Cancer diagram by ibreakstock, Shutterstock
ibreakstock, Shutterstock

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Top 20 most recent papers
Journal of Hematology & Oncology

Vasculogenic mimicry in carcinogenesis and clinical applications

Journal of Hematology & OncologyMarch 15, 2020
Qingxi LuoChaojun Duan
2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V

Improving Tumor Hypoxia and Radiotherapy Resistance via in situ Nitric Oxide Release Strategy

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.VMarch 11, 2020
Jingyao TuZhiping Zhang
1
International Journal of Molecular Sciences

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

International Journal of Molecular SciencesApril 2, 2020
Masahiro KagabuTsukasa Baba
Seminars in Nephrology

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in NephrologyMarch 5, 2020
Edgar A Jaimes
2
Theranostics

The biological implications of Yin Yang 1 in the hallmarks of cancer

TheranosticsApril 1, 2020
Ian Timothy Sembiring MelialaShourong Wu
Oncoimmunology

Lactate dehydrogenase: a marker of diminished antitumor immunity

OncoimmunologyMarch 12, 2020
Sandra Van WilpeNiven Mehra
1
Cirugía española

Results of a national survey on the use of stents for the treatment of colonic obstruction

Cirugía españolaMarch 30, 2020
Natalia Alonso-HernándezXavier Francesc González-Argente
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)

Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)March 18, 2020
Andrea FerrariMichela Casanova
2
Frontiers in Oncology

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer

Frontiers in OncologyMarch 17, 2020
Yolla HaibeAli Shamseddine
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer

Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in CancerMarch 8, 2020
Wanessa Miranda-SilvaEduardo Rodrigues Fregnani

See more papers from this feed

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2020 Meta ULC. All rights reserved
/feed-previews/angiogenesis-inhibitors-to-treat/91da804f-fb64-43c0-b5d5-7a6ecb289e43